Almost 1 out of every 3 HealthCare.gov plans want rate hikes of more than 10 percent next year.» Read More
An audit said there were ineffective internal controls to ensure that $2.8 billion given insurers was accurately disbursed.
Some think it is unlikely that a round of consolidation in the health insurance industry will push prices higher for consumers.
Here's what the bills might look like for 6.4 million HealthCare.gov customers if subsidies go away.
Allergan's acquisition of Kythera expands the company's footprint of the facial treatment space, CNBC's Jim Cramer said.
India's system for training doctors is plagued by fraud and unprofessional teaching practices, worsening public health issues, Reuters reports.
Hill-Rom Holdings said it would buy privately held Welch Allyn for about $2.05 billion to expand into the point-of-care diagnostics market.
Americans place controlling drug costs at the top of their health-related concerns.
Just 27% of people know about King v. Burwell, a Supreme Court case that threatens to cripple Obamacare in 34 HealthCare.gov states.
Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine.
CVS is buying Target's pharmacy business, but the deal shouldn't raise antitrust concerns or prices, NBC News reports.
Many of those happy with their new health plans could lose coverage because of a pending Supreme Court case.
Cigna rejected a takeover approach from larger health insurer Anthem as health-care consolidation continues, Dow Jones reported.
CVS Health and Target on Monday announced a deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.
South Korea's MERS outbreak is "large and complex" and more cases should be expected, but there's no sign it's spreading in the community, WHO said.
An NYC proposal would require chains to add a salt shaker image next to food that contains more than the recommended sodium level.
Most HealthCare.gov states are not expected to act quickly enough to maintain Obamacare subsidies if the Supreme Court ends them.
OraSure Technologies' test, which takes 20 minutes for results, could help stop the spread of Ebola in an outbreak.
How Alzheimer's drug Solanezumab works to help treat the underlying cause of the disease, with CNBC's Meg Tirrell.
TeVido BioDevices is creating a 3-D-printed female nipple, after a surge in breast cancer mastectomies created a huge health-care issue.
The real reason payroll giant ADP blocked HR start-up Zenefits from accessing its systems is fear, Zenefits co-founder and CEO Parker Conrad tells CNBC.
Get the best of CNBC in your inbox